Heme oxygenase activity and hemoglobin neurotoxicity are attenuated by inhibitors of the MEK/ERK pathway
- 30 April 2009
- journal article
- Published by Elsevier in Neuropharmacology
- Vol. 56 (5) , 922-928
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Pharmacological and Clinical Aspects of Heme OxygenasePharmacological Reviews, 2008
- Heme oxygenase-1 exacerbates early brain injury after intracerebral haemorrhageBrain, 2007
- Microglial cells in astroglial cultures: a cautionary noteJournal of Neuroinflammation, 2007
- A Death-Promoting Role for Extracellular Signal-Regulated KinaseThe Journal of Pharmacology and Experimental Therapeutics, 2006
- Effect of heme oxygenase-1 on the vulnerability of astrocytes and neurons to hemoglobinBiochemical and Biophysical Research Communications, 2006
- Inhibition of the ERK/MAP kinase pathway attenuates heme oxygenase-1 expression and heme-mediated neuronal injuryNeuroscience Letters, 2006
- Identification of a selective ERK inhibitor and structural determination of the inhibitor–ERK2 complexBiochemical and Biophysical Research Communications, 2005
- Protein kinase Akt/PKB phosphorylates heme oxygenase‐1 in vitro and in vivoFEBS Letters, 2004
- Hemin: levels in experimental subarachnoid hematoma and effects on dissociated vascular smooth-muscle cellsJournal of Neurosurgery, 1993
- Neurotoxicity of hemoglobin in cortical cell cultureNeuroscience Letters, 1993